Versiti acquires Texas-based Cenetron Central Laboratories and Salus IRB to advance clinical trial capabilities

Milwaukee, Wisconsin, July 12, 2019 – Versiti, a national leader in blood health innovation, today announced the acquisition of Texas-based Cenetron Central Laboratories, and its subsidiary, Salus IRB, offering both organizations the opportunity to expand clinical trial services and expertise.

Read More >>

Salus IRB Announces Name Change

Austin, Texas, March 10, 2014 – RCRC IRB announced today that its organization has changed its name to Salus IRB. The management, administrative staff, ownership structure, and review board memberships remain unchanged.

Read More >>

Salus IRB Announces Addition of Third Review Board

Austin, Texas, September 02, 2013 – RCRC IRB announced today that it has added an additional review board for continued customer service enhancement. Alexander Kenaston chairs the additional board. Dr. Kenaston has over ten years’ experience in the IRB and research fields. Dr. Jennifer Christensen, a previous researcher, is the vice-chair of the new board. Both Dr. Kenaston and Dr. Christensen have experience serving on academic institutional IRBs and commercial or independent IRBs.

Read More >>